brand names of glp 1 drugs glp-1 receptor agonist Middle East & Africa Glucagon-like Peptide-1 (GLP-1) Agonists Market Report GLP-1 Medications for Weight Loss:

Zhou B, Zissimopoulos J, Nadeem H, Crane MA, Goldman D, Romley JA

The 2022 ASMBS/IFSO guidelines recommend consideration for patients with BMI 35 kg/m regardless of comorbidities, and for those with BMI 30-34.9 kg/m with metabolic disease

Some are the same drug in different doses

The new Eli Lilly pill is orforglipron, an oral GLP-1 medication designed to support weight loss and improve blood sugar

The medications now target multiple organ systems, including the pancreas, stomach, brain, heart, kidneys, immune system, skeletal muscle, adipose tissue, and liver, addressing multiple chronic conditions simultaneously rather than just treating obesity